Target intelligence / Profile preview

DEPDC1 antisense RNA 2 (DEPDC1-AS2)

Target
DEPDC1-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other (non-coding RNA)
01

Overview

DEPDC1-AS2 is an uncharacterized lncRNA transcribed antisense to the DEPDC1 gene. No validated function, biological pathway, or disease association has been published as of the current date. Related lncRNAs in the DEPDC1 locus are active in cancer, but this specific molecule lacks experimental evidence.

Other names
DEPDC1-AS2RP4-694A7.2
02

Biological functions

Other (not confirmed)
03

Disease associations

Other (not confirmed)

Beyond the preview

Go deeper on DEPDC1 antisense RNA 2 (DEPDC1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEPDC1 antisense RNA 2 (DEPDC1-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call